Shenyang Bomei Pharmaceutical New Technology Development Co., Ltd.
Profile: Shenyang Bomei Pharmaceutical New Technology Development Co., Ltd. is engaged in the production and trade of pharmaceutical materials & intermediates. Our API series include otilonium bromide, calcium phenylpyruvate, memantine hydrochloride, ketanserin tartrate, cefquinome sulfate, indocyanine green, zinc ceftiofur, melitracen hydrochloride and rebeprazole sodium. We offer intermediates such as 3,5-dimethylacetophenone, 1-bromo-3,5-dimethyladamantane, isonicotinoyl chloride hydrochloride, 2-methoxy-4-methylsulfonylaniline, nicotinoyl chloride hydrochloride, monoacetyl guanidine, hinokitiol and 4-quinolinecarboxaldehyde.